Sign in
Groups
Researchers
Results
Funding
Convener
:
ALCON HEALTHCARE S.A.
Scope
International (non-EU) (1)
1 funding
- 42,404€
data available since 2022
2022
Effect of treatment with Systane Ultra in symptomatology and visual task efficiency in digital device users.
euro
42,404.00
Contact
Legal notice
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de